A detailed history of Formidable Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Formidable Asset Management, LLC holds 12,397 shares of BMY stock, worth $659,396. This represents 0.09% of its overall portfolio holdings.

Number of Shares
12,397
Previous 13,432 7.71%
Holding current value
$659,396
Previous $728,000 29.4%
% of portfolio
0.09%
Previous 0.12%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $41,658 - $54,844
-1,035 Reduced 7.71%
12,397 $514,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $53,689 - $60,873
1,119 Added 9.09%
13,432 $728,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $17,367 - $19,419
-300 Reduced 2.38%
12,313 $714,000
Q1 2023

May 09, 2023

BUY
$65.71 - $74.53 $6,570 - $7,453
100 Added 0.8%
12,613 $877,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $0 - $537
-7 Reduced 0.06%
12,513 $918,000
Q2 2022

Aug 16, 2022

SELL
$72.62 - $79.98 $937,161 - $1.03 Million
-12,905 Reduced 50.76%
12,520 $946,000
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $21,026 - $25,212
342 Added 1.36%
25,425 $1.86 Million
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $99,376 - $115,849
1,853 Added 7.98%
25,083 $1.56 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $732,702 - $858,265
12,383 Added 114.16%
23,230 $1.38 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $655,564 - $713,910
10,589 Added 4104.26%
10,847 $729,000
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $638,849 - $695,706
-10,319 Reduced 97.56%
258 $558,000
Q1 2021

May 12, 2021

BUY
$59.34 - $66.74 $22,311 - $25,094
376 Added 3.69%
10,577 $667,000
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $1,385 - $1,570
-24 Reduced 0.23%
10,201 $629,000
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $5,743 - $6,364
-100 Reduced 0.97%
10,225 $606,000
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $46,871 - $54,796
855 Added 9.03%
10,325 $609,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $466,018 - $607,879
9,470 New
9,470 $631,000
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $334,504 - $396,602
-7,821 Closed
0 $0
Q2 2019

Oct 15, 2019

BUY
$44.62 - $49.34 $348,973 - $385,888
7,821 New
7,821 $348,000
Q4 2018

Feb 06, 2019

SELL
$48.76 - $63.23 $593,214 - $769,256
-12,166 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $95,754 - $108,003
-1,735 Reduced 12.48%
12,166 $762,000
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $50,428 - $62,854
998 Added 7.73%
13,901 $769,000
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $8,568 - $9,864
-143 Reduced 1.1%
12,903 $816,000
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $2,997 - $3,267
-50 Reduced 0.38%
13,046 $800,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $723,292 - $834,739
13,096
13,096 $835,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.